Sensei Biotherapeutics In... (SNSE)
undefined
undefined%
At close: undefined
0.51
-2.28%
After-hours Jan 06, 2025, 07:52 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -0.57 -0.94 -4.29 -28.02 -29.18 -0.99
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 0.30 0.44 1.10 -10.24 -8.07 -0.24
P/FCF Ratio -0.6 -1.16 -4.98 -30.57 -64.27 -1.25
P/OCF Ratio -0.6 -1.17 -5.31 -32.65 -64.67 -1.26
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio n/a 0.02 0.00 -0.01 -0.23 -0.09
Quick Ratio 11.92 11.98 30.38 4.16 0.02 0.48
Current Ratio 11.92 11.98 30.38 4.16 0.02 0.48
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage -257.39 -229.17 -55.94 -11.52 -5.51 -38.96
Return on Equity (ROE) -0.53 -0.47 -0.26 0.37 0.28 0.24
Return on Assets (ROA) -0.46 -0.41 -0.24 -0.96 -15.61 -7.05
Return on Capital (ROIC) -0.54 -0.46 -0.25 -1.17 0.61 15.67
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a